Evidence map›Paper›PMID 29985529›Full record

ArticleJournal of leukocyte biology2018

Gr1

Kyle K Payne, Hussein F Aqbi, Savannah E Butler, Laura Graham, Rebecca C Keim, Wen Wan, Michael O Idowu, Harry D Bear, Xiang-Yang Wang, Masoud H Manjili

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of leukocyte biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Restoration of CD4Cancers · 2022
    Article
  2. Article
  3. Article
  4. Gr1Journal of leukocyte biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kyle K PayneDepartment of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Hussein F AqbiDepartment of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Savannah E ButlerDepartment of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Laura GrahamMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Rebecca C KeimDepartment of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Wen WanMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Michael O IdowuMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Harry D BearMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Xiang-Yang WangMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Masoud H ManjiliDepartment of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Virginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Large heat shock proteins and their role in cancer therapyR01CA099326 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A, WANG, XIANG-YANG SHAWN · 2003 to 2020
$5.7M
1/2-Neurotoxicant exposures:impact maternal and child health in Suriname-SurinameU01TW010087 · FIC · ACADEMISCH ZIEKENHUIS PARAMARIBO · PI LICHTVELD, MAUREEN Y., MANS, DENNIS R.A. · 2015 to 2020
$1.9M
Host-tumor interactions and cancer relapse after radiation therapyR01CA175033 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI WANG, XIANG-YANG SHAWN · 2014 to 2018
$1.6M
American Association of ImmunologistsNCI NIH HHS P30 CA016059NCI NIH HHS R01 CA099326NCI NIH HHS R01 CA175033NIH/NCI Cancer Center P30 CA016059Office of the Assistant Secretary of Defense for Health Affairs W81XWH-14-1-0087VCU Massey Cancer Center
6 · The paper itself

Abstract

Conventional APCs that express MHC class II (MHCII) and co-stimulatory molecules include dendritic cells (DCs) and macrophages. Beyond these conventional APCs, immune stimulatory cells have been more recently shown to extend to a class of atypical APCs, composed of mast cells, basophils, and eosinophils. Here, we describe a unique type of APC, Gr1

Indexed as

AnimalsAntigen-Presenting CellsCD11b AntigenCell LineageCells, CulturedCytotoxicity, ImmunologicFemaleImmunotherapy, AdoptiveKiller Cells, NaturalLung NeoplasmsLymphocytes, Tumor-InfiltratingMammary Neoplasms, ExperimentalMiceMice, TransgenicMyeloid CellsReceptors, ChemokineCD11b AntigenGr-1 protein, mouseReceptors, Chemokineadoptive immunotherapyAg presenting cellsbreast cancercancer vaccinemyeloid-derived suppressor cells

Identifiers

PMID29985529
PMCPMC6258302
OpenAlexW2851939145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.